| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6653999
[patent_doc_number] => 20030077240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Use of high-purity phenylsilsesquioxane liquids for the preparation of cosmetic and pharmaceutical compositions'
[patent_app_type] => new
[patent_app_number] => 10/002709
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4510
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20030077240.pdf
[firstpage_image] =>[orig_patent_app_number] => 10002709
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/002709 | Use of high-purity phenylsilsesquioxane liquids for the preparation of cosmetic and pharmaceutical compositions | Oct 23, 2001 | Abandoned |
Array
(
[id] => 6687990
[patent_doc_number] => 20030031715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof'
[patent_app_type] => new
[patent_app_number] => 09/975800
[patent_app_country] => US
[patent_app_date] => 2001-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19466
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031715.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975800
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975800 | Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof | Oct 10, 2001 | Abandoned |
Array
(
[id] => 623211
[patent_doc_number] => 07138133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-11-21
[patent_title] => 'Orally administered liquid compositions'
[patent_app_type] => utility
[patent_app_number] => 09/974347
[patent_app_country] => US
[patent_app_date] => 2001-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7099
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/138/07138133.pdf
[firstpage_image] =>[orig_patent_app_number] => 09974347
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/974347 | Orally administered liquid compositions | Oct 9, 2001 | Issued |
| 09/868261 | Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia | Oct 4, 2001 | Abandoned |
Array
(
[id] => 6344274
[patent_doc_number] => 20020035131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Regimen and kit for amelioration of premature ejaculation'
[patent_app_type] => new
[patent_app_number] => 09/970293
[patent_app_country] => US
[patent_app_date] => 2001-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13664
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20020035131.pdf
[firstpage_image] =>[orig_patent_app_number] => 09970293
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/970293 | Regimen and kit for amelioration of premature ejaculation | Oct 2, 2001 | Abandoned |
Array
(
[id] => 6128457
[patent_doc_number] => 20020076425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Cosmetic compositions comprising at least one continuous liquid fatty phase structured with polyurethanes, polyurethaneureas, and polyureas'
[patent_app_type] => new
[patent_app_number] => 09/964751
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7203
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076425.pdf
[firstpage_image] =>[orig_patent_app_number] => 09964751
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/964751 | Cosmetic compositions comprising at least one continuous liquid fatty phase structured with polyurethanes, polyurethaneureas, and polyureas | Sep 27, 2001 | Abandoned |
Array
(
[id] => 6128457
[patent_doc_number] => 20020076425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Cosmetic compositions comprising at least one continuous liquid fatty phase structured with polyurethanes, polyurethaneureas, and polyureas'
[patent_app_type] => new
[patent_app_number] => 09/964751
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7203
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076425.pdf
[firstpage_image] =>[orig_patent_app_number] => 09964751
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/964751 | Cosmetic compositions comprising at least one continuous liquid fatty phase structured with polyurethanes, polyurethaneureas, and polyureas | Sep 27, 2001 | Abandoned |
Array
(
[id] => 6241296
[patent_doc_number] => 20020044921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Pegylated interleukin-10'
[patent_app_type] => new
[patent_app_number] => 09/967223
[patent_app_country] => US
[patent_app_date] => 2001-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8025
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20020044921.pdf
[firstpage_image] =>[orig_patent_app_number] => 09967223
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/967223 | Pegylated interleukin-10 | Sep 27, 2001 | Issued |
Array
(
[id] => 1139128
[patent_doc_number] => 06780886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-24
[patent_title] => 'Antioxidant containing vitamin E metabolite'
[patent_app_type] => B2
[patent_app_number] => 09/963365
[patent_app_country] => US
[patent_app_date] => 2001-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1643
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/780/06780886.pdf
[firstpage_image] =>[orig_patent_app_number] => 09963365
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/963365 | Antioxidant containing vitamin E metabolite | Sep 26, 2001 | Issued |
Array
(
[id] => 7429153
[patent_doc_number] => 20040001800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Hemo-and biocompatible polymeric adsorbing material, method of producing the material, and method of and device for purification of physiological fluids of organism with the use of the material'
[patent_app_type] => new
[patent_app_number] => 09/961781
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3189
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001800.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961781
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961781 | Hemo-and biocompatible polymeric adsorbing material, method of producing the material, and method of and device for purification of physiological fluids of organism with the use of the material | Sep 23, 2001 | Abandoned |
Array
(
[id] => 1188556
[patent_doc_number] => 06733787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-11
[patent_title] => 'Bioerodable polymeric adhesives for tissue repair'
[patent_app_type] => B2
[patent_app_number] => 09/956390
[patent_app_country] => US
[patent_app_date] => 2001-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10424
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/733/06733787.pdf
[firstpage_image] =>[orig_patent_app_number] => 09956390
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/956390 | Bioerodable polymeric adhesives for tissue repair | Sep 18, 2001 | Issued |
Array
(
[id] => 1164640
[patent_doc_number] => 06759437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-06
[patent_title] => 'Comprehensive pharmacologic therapy for treatment of obesity including cysteine'
[patent_app_type] => B2
[patent_app_number] => 09/947941
[patent_app_country] => US
[patent_app_date] => 2001-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7318
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759437.pdf
[firstpage_image] =>[orig_patent_app_number] => 09947941
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/947941 | Comprehensive pharmacologic therapy for treatment of obesity including cysteine | Sep 5, 2001 | Issued |
Array
(
[id] => 6032169
[patent_doc_number] => 20020018813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers'
[patent_app_type] => new
[patent_app_number] => 09/946121
[patent_app_country] => US
[patent_app_date] => 2001-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6762
[patent_no_of_claims] => 98
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20020018813.pdf
[firstpage_image] =>[orig_patent_app_number] => 09946121
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/946121 | Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers | Sep 3, 2001 | Issued |
Array
(
[id] => 1413582
[patent_doc_number] => 06509037
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-01-21
[patent_title] => 'Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof'
[patent_app_type] => B2
[patent_app_number] => 09/945056
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1438
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/509/06509037.pdf
[firstpage_image] =>[orig_patent_app_number] => 09945056
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/945056 | Sustained release pharmaceutical matrix tablet of pharmaceutically acceptable salts of diclofenac and process for preparation thereof | Aug 30, 2001 | Issued |
Array
(
[id] => 6623268
[patent_doc_number] => 20020065311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Comprehensive pharmacologic therapy for treatment of obesity'
[patent_app_type] => new
[patent_app_number] => 09/943462
[patent_app_country] => US
[patent_app_date] => 2001-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5489
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065311.pdf
[firstpage_image] =>[orig_patent_app_number] => 09943462
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/943462 | Comprehensive pharmacologic therapy for treatment of obesity | Aug 29, 2001 | Issued |
Array
(
[id] => 6210081
[patent_doc_number] => 20020072537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'Comprehensive pharmacologic therapy for treatment of obesity'
[patent_app_type] => new
[patent_app_number] => 09/942188
[patent_app_country] => US
[patent_app_date] => 2001-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5488
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20020072537.pdf
[firstpage_image] =>[orig_patent_app_number] => 09942188
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/942188 | Comprehensive pharmacologic therapy for treatment of obesity | Aug 28, 2001 | Issued |
Array
(
[id] => 6598699
[patent_doc_number] => 20020042401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'Use of sex steroids function modulators to treat wounds and fibrotic disorders'
[patent_app_type] => new
[patent_app_number] => 09/939611
[patent_app_country] => US
[patent_app_date] => 2001-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13089
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042401.pdf
[firstpage_image] =>[orig_patent_app_number] => 09939611
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/939611 | Use of sex steroids function modulators to treat wounds and fibrotic disorders | Aug 27, 2001 | Issued |
Array
(
[id] => 6032157
[patent_doc_number] => 20020018810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Controlled release oxycodone compositions'
[patent_app_type] => new
[patent_app_number] => 09/933411
[patent_app_country] => US
[patent_app_date] => 2001-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8661
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20020018810.pdf
[firstpage_image] =>[orig_patent_app_number] => 09933411
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/933411 | Controlled release oxycodone compositions | Aug 19, 2001 | Abandoned |
Array
(
[id] => 6749916
[patent_doc_number] => 20030044436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Topical composition, topical composition precursor, and methods for manufacturing and using'
[patent_app_type] => new
[patent_app_number] => 09/933275
[patent_app_country] => US
[patent_app_date] => 2001-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9424
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044436.pdf
[firstpage_image] =>[orig_patent_app_number] => 09933275
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/933275 | Topical composition, topical composition precursor, and methods for manufacturing and using | Aug 19, 2001 | Issued |
Array
(
[id] => 1164580
[patent_doc_number] => 06759431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-06
[patent_title] => 'Compositions and methods for treating or preventing diseases of body passageways'
[patent_app_type] => B2
[patent_app_number] => 09/933652
[patent_app_country] => US
[patent_app_date] => 2001-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 95
[patent_figures_cnt] => 143
[patent_no_of_words] => 43754
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759431.pdf
[firstpage_image] =>[orig_patent_app_number] => 09933652
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/933652 | Compositions and methods for treating or preventing diseases of body passageways | Aug 19, 2001 | Issued |